FDA Accuses 2 Drug Cos. Of Marketing Unapproved Opioid
Durect Corp. and Pain Therapeutics Inc. are violating the Food, Drug and Cosmetic Act by making statements about the safety and effectiveness of their opioid painkiller Remoxy ER before it's been...To view the full article, register now.
Already a subscriber? Click here to view full article